Pillet, Stéphane
Aubin, Éric
Trépanier, Sonia
Poulin, Jean-François
Yassine-Diab, Bader
ter Meulen, Jan
Ward, Brian J.
Landry, Nathalie
Article History
Received: 2 June 2017
Revised: 11 December 2017
Accepted: 15 December 2017
First Online: 23 January 2018
Competing interests
: B.J.W. has been a principal investigator of vaccine trials for several manufacturers, including Medicago Inc., for which his institution obtained research contracts. Since 2010, B.J.W. served as Medical Officer for Medicago Inc. In addition, B.J.W. has held and continued to hold peer-reviewed support from Canadian Institutes of Health Research and other sources for collaborative, basic science work with Medicago Inc. B.J.W. has received honoraria from several vaccine manufacturers for participation on Scientific Advisory Boards (including Medicago Inc). N.L., S.T., S.P. and É.A. are employees of Medicago Inc. J.M. is a full-time employee and shareholder of Immune Design. The remaining authors declare no competing financial interests.